BANGALORE (Dow Jones)--Indian drug maker Glenmark Pharmaceuticals Ltd. (532296.BY) and U.S. partner Lehigh Valley Technologies Inc. said Monday the U.S. Food and Drug Administration has approved two new-drug applications that will allow the companies to manufacture and sell a line of products containing painkiller oxycodone hydrochloride.
